Epithelial Regeneration After Doxorubicin Arises Primarily From Early Progeny of Active Intestinal Stem Cells
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 12 (1) , 119-140
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of War
- National Institute of Allergy and Infectious Diseases (U19AI067773)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30-DK34933, R01DK118023, W81XWH-19-1-0170)
- School of Medicine, Duke University
- College of Veterinary Medicine, North Carolina State University
This publication has 67 references indexed in Scilit:
- The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor SuppressorCell, 2012
- The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populationsProceedings of the National Academy of Sciences of the United States of America, 2011
- A Quantitative Proteomic Approach of the Different Stages of Colorectal Cancer Establishes OLFM4 as a New Nonmetastatic Tumor MarkerMolecular & Cellular Proteomics, 2011
- Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomesThe EMBO Journal, 2011
- Mouse telomerase reverse transcriptase (mTert) expression marks slowly cycling intestinal stem cellsProceedings of the National Academy of Sciences, 2010
- Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem CellsCell, 2010
- Stem Cells, Self-Renewal, and Differentiation in the Intestinal EpitheliumAnnual Review of Physiology, 2009
- Topoisomerase levels determine chemotherapy response in vitro and in vivoProceedings of the National Academy of Sciences, 2008
- Bmi1 is expressed in vivo in intestinal stem cellsNature Genetics, 2008
- Identification of stem cells in small intestine and colon by marker gene Lgr5Nature, 2007